Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Dermatologic 2Breast 2Tumor-Agnostic 1Sarcoma 1

Conditions

Endometrial Neoplasms 2Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 153Carboplatin 123Bevacizumab 87Cisplatin 66pembrolizumab 58Taxes 51Gemcitabine 51liposomal doxorubicin 39Topotecan 37olaparib 31Immunoglobulin G 27Disulfides 26Cyclophosphamide 24Brachytherapy 22Docetaxel 21human papillomavirus vaccine, L1 type 16, 18 20niraparib 19Platinum 19Nivolumab 18Magnetic Resonance Spectroscopy 181,2-diaminocyclohexaneplatinum II citrate 18rucaparib 17durvalumab 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 16Doxorubicin 16Radiotherapy, Intensity-Modulated 14Radiation 13Albumin-Bound Paclitaxel 13fludarabine phosphate 12fludarabine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × iso-sulfan blue × Gynecologic × Clear all
NCT01818739 2023-03-22

Lymph Node Mapping in Patients With Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
204 enrolled 4 charts
Gynecologic

Endometrial Neoplasms

NCT01939028 2020-08-27

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Case Comprehensive Cancer Center

Phase NA Terminated
58 enrolled 12 charts
Gynecologic

Endometrial Neoplasms

NCT00070317 2017-11-06

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

GOG Foundation

Phase NA Terminated
102 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡